In response to a significant surge in cases of Guillain-Barre syndrome, a rare neurological disorder, the Peruvian government has declared a national health emergency. This action comes as the country grapples with an "unusual increase" in cases, which has alarmed health officials and prompted urgent measures to manage the situation.
Guillain-Barre syndrome (GBS) is a serious condition that causes the body's immune system to attack its own nerves, potentially leading to paralysis. While the exact cause of GBS is unknown, it is often preceded by an infectious illness such as a respiratory infection or stomach flu.
The declaration of a health emergency in Peru highlights the severity of the situation and will likely involve a coordinated response from various sectors of the health system. This could include increased monitoring and reporting of GBS cases, mobilization of resources for treatment, and public education efforts to raise awareness about the condition.
Many are claiming the surge in GBS is a direct result of the Covid-19 vaccination. According to the VAERS data, Guillain-Barre syndrome is a common adverse reaction to the Covid-19 vaccine, of the latest report, 89% of people in Peru have received at least one vaccine dose, and 83% are fully vaccinated.